Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the first new FDA-approved treatment for fibromyalgia in ad ...
Erosive tooth wear (ETW) represents a rapidly evolving area within dental medicine, drawing increasing attention due to its multifactorial etiology and ...
Introduction Common mental health outcomes among children in conflict with the law in correctional facilities in Africa are an under-researched area with significant public health implications. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results